Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: LMA Proseal: Patients will be allotted after written informed consent is given by them and they will be allotted in two groups: group A & group B according to sequential randomization m
Sponsors
Institute of Liver and Biliary Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients of ASA grade I, II, III undergoing hepatobiliary surgery in Institute of liver and biliary science where expected duration of surgery is = 6 hours and gut handling during surgery is minimal
Exclusion criteria
Exclusion criteria: Patients with anticipated difficult airway Inadequate NPO status Obese, BMI more than 35 ASA grade IV, V with serious comorbidities. Emergency surgeries Patient who has not given consent to participate in study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Objective is to assess feasibility of LMA Proseal by means of ventilatory efficacy and pulmonary gas exchange in prolonged hepatobiliary surgery and to compare its efficacy with endotracheal tube. Ventilatory efficacy will be evaluated by means of peak pressure, driving pressure, leak (discrepancy between inspiratory and expiratory tidal volume). Pulmonary gas exchange will be evaluated as PaO2, PaCO2, ETCO2. Timepoint: base line, hourly parameter at 1st,2nd,3rd,4th,5th,6th, 7th,8th hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic variation during insertion and emergenceTimepoint: baseline, 0,1,3,5,10 minutes after insertion of LMA or ET tube, after discontinuation of anesthesia,time of extubation, 5 minutes post extubation;incidence of post operative nausea vomiting, postoperative pulmonary complications, hoarseness of voice, sore throatTimepoint: up to 3 days post surgery | — |
Countries
India
Contacts
Public ContactDr Aniruddha Banerjee
Institute of Liver & Biliary Sciences
Outcome results
None listed